Home » Press Release » 2014 » December 2, 2014

December 2, 2014

Alethia Biotherapeutics announces the issuance of U.S. Patent No. 8,900,579¬†entitled “Siglec-15 antibodies in treating bone loss-related diseases” by the United States Patent and Trademark Office (“USPTO”)